Doctor Frederic Tremblay

Boston (United States of America)

Follow

Contributor content

An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates

Presentation

An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates

ESC 365 is supported by

novartis

Explore sponsored resources